Missouri Colleges MO

Nasal COVID-19 vaccine based on WashU technology to enter U.S. clinical trials

Washington University in St. Louis

Feb 6, 2025

A nasal vaccine for COVID-19 - based on technology developed at Washington University in St. Louis - is poised to enter a phase 1 clinical trial in the U.S. after an investigationa…

Read the full story at Washington University in St. Louis

Topics

#Coronavirus #Washington University in St. Louis

Nasal COVID-19 vaccine based on WashU technology to enter U.S. clinical trials

Topics

More from Missouri Colleges

Faculty invited to apply for Digital Transformation Research Corps

Naseh to receive International Institute of St. Louis award

Locusts get a sensory assist from nanomaterials

WashU Medicine names new chair of pediatrics

Sterling Lawrence: 'It Is What It Is When It Is'

New discovery may point to clues about how head and neck cancers spread

Prize supports hunt for broad-spectrum antivirals

Vaccinating moms protects offspring from deadly superbug